Comprehensive Mesothelioma Program
Since 1997, UCLA's Comprehensive Mesothelioma Program has been using lung-sparing surgery and innovative postoperative therapies that stress quality of life as well as survival. Patients benefit from UCLA's expertise in performing a meticulous procedure (pleurectomy and decortication) that removes all visible tumor from the chest while sparing normal structures, such as the lung, pericardium and diaphragm.
The surgery is followed by precise radiation therapy to target remaining cancer cells and avoid injury to the preserved lung. Patients also benefit from a number of existing and investigational therapies to target the remaining microscopic disease and slow its re-growth.
Recognizing that mesothelioma cannot be entirely eliminated from the body, our physicians treat it as they would any chronic condition. That means we use frequent (often daily) well-tolerated therapies to slow its growth rather than using concentrated treatments whose toxicities may be excessive. UCLA has pioneered the use of therapies such as immunotherapy and cryoablation, which have led to significant advances in the care of patients with this condition. Dr. Robert Cameron founded the program.
Treatment of sarcomatoid mesothelioma
Patients with sarcomatoid mesothelioma benefit from UCLA's expertise in this rare disease. We have found that chemotherapy agents typically used to treat sarcomas in other areas of the body are more effective in these patients than are the typical mesothelioma chemotherapy agents. This chemotherapy, followed by surgery and radiation, has provided significant advantages for patients in this small group. All patients are treated by a multidisciplinary team. A dedicated nurse practitioner helps to coordinate care and is available to answer questions from patients and referring physicians.
Research
UCLA Comprehensive Mesothelioma Program physicians collaborate with basic scientists at UCLA, West Los Angeles VA Medical Center, and the Pacific Meso Center at the Pacific Heart, Lung, & Blood Institute.
Our Services
Patients with all stages of mesothelioma are provided with expert surgical, radiation and medical oncology services.
- Surgical techniques include lung-sparing tumor surgery (pleurectomy and decortication or P/D), lasers, bronchial (airway) and esophageal stents and video-and computer-assisted robotic surgery
- Radiation therapy techniques include stereotactic body radiation therapy (SBRT), intensity-modulated radiation therapy (IMRT) and radiosurgery using the Novalis Tx image-guided system
- Chemotherapy, immunotherapy and targeted biologic agents are chosen based on extensive experience treating mesothelioma
Contact Information
Thoracic Surgery
(310) 470-8980 (Cameron)
(310) 794-7333 (J. Lee & Yanagawa)
Medical Oncology
(310) 829-5471 (Olevsky)
Radiation Oncology
(310) 825-9775 (P. Lee)
Physicians & Specialists
Specialty
Cardiothoracic Surgery; Surgical Oncology
Faculty Denise Aberle, MD Fereidoun Abtin, MD Adam Brown MD Kathleen Brown, MD Johannes Czernin, MD Michael Fishbein, MD Nir Hoftman, MD Jay Lee, MD Percy Lee, MD James Moore, MD Olevsky, Olga MD Parisa Partownavid, MD Siamak Rahman, MD Christiaan Schiepers, MD, PhD Robert Suh, MD William Wallace, MD Jane Yanagawa, MD
Diagnostic Radiology
Diagnostic Radiology
Anesthesiology
Diagnostic Radiology
Nuclear Medicine
Anatomic Pathology & Clinical Pathology
Anesthesiology
Cardiothoracic Surgery
Radiation Oncology
Anesthesiology
Hematology & Oncology
Anesthesiology
Anesthesiology
Nuclear Medicine
Diagnostic Radiology
Anatomic Pathology & Clinical Pathology
Cardiothoracic Surgery
Cardiothoracic Surgery
Cardiothoracic Surgery
Research Scientists
Dongmei Hou, PhD
Irina Ianculescu, PhD
Raymond Wong, PhD
